연구동향 분석

Meta-Analysis : Effect of Prucalopride in the Treatment of Chronic Constipation in Asian and Non-Asian Women: A Pooled Analysis of 4 Randomized,Placebo-controlled Studies

( Mei Yun Ke ) ( Jan Tack ) ( Eamonn M M Quigley ) ( Duo Wu Zou ) ( Suck Chei Choi ) ( Somchai Leelakusolvong ) ( Andy Liu ) ( Jin Yong Kim ) 2014년

논문상세정보
인용/피인용
' Meta-Analysis : Effect of Prucalopride in the Treatment of Chronic Constipation in Asian and Non-Asian Women: A Pooled Analysis of 4 Randomized,Placebo-controlled Studies' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • asianwomen
  • chronicconstipation
  • non-asianwomen
  • prucalopride
  • serotonin5-ht4receptoragonists
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
19 0

0.0%

' Meta-Analysis : Effect of Prucalopride in the Treatment of Chronic Constipation in Asian and Non-Asian Women: A Pooled Analysis of 4 Randomized,Placebo-controlled Studies' 의 참고문헌

  • World Gastroenterology Organisation global guideline: Constipation-a global perspective
    Lindberg G J Clin Gastroenterol 45 : 483 ~ 487 - [2011]
  • The health-related quality of life and economic burden of constipation
    Dennison C Pharmacoeconomics 23 : 461 ~ 476 - [2005]
  • The effects of the specific 5HT4 receptor agonist, prucalopride, on colonic motility in healthy volunteers
    De Schryver AM Aliment Pharmacol Ther 16 : 603 ~ 612 [2002]
  • Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders
    Tack J Aliment Pharmacol Ther 35 : 745 ~ 767 - [2012]
  • Psychometric validation of a constipation symptom assessment questionnaire
    Frank L Scand J Gastroenterol 34 : 870 ~ 877 - [1999]
  • Prucalopride: safety, efficacy and potential applications
    Quigley EM Therap Adv Gastroenterol 5 : 23 ~ 30 - [2012]
  • Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation
    Tack J Expert Opin Drug Metab Toxicol 8 : 1327 ~ 1335 - [2012]
  • Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
    Ke M Neurogastroenterol Motil 24 : 999 ~ - [2012]
  • Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives
    Tack J Gut 58 : 357 ~ 365 - [2009]
  • Prevalence of gastrointestinal symptoms in the elderly: a population-based study
    Talley NJ Gastroenterology 102 : 895 ~ 901 - [1992]
  • Levels of satisfaction with current chronic constipation treatment options in Europe - an internet survey
    Muller-Lissner S Aliment Pharmacol Ther 37 : 137 ~ 145 - [2013]
  • Lack of objective evidence of efficacy of laxatives in chronic constipation
    Jones MP Dig Dis Sci 47 : 2222 ~ 2230 - [2002]
  • Functional bowel disorders
    Longstreth GF Gastroenterology 130 : 1480 ~ 1491 - [2006]
  • Epidemiology of constipation in North America: a systematic review
    Higgins PD Am J Gastroenterol 99 : 750 ~ 759 - [2004]
  • Epidemiology of constipation in Europe and Oceania: a systematic review
    Peppas G BMC Gastroenterol 8 : 5 ~ - [2008]
  • Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features
    Stewart WF Am J Gastroenterol 94 : 3530 ~ 3540 - [1999]
  • Epidemiology and burden of chronic constipation
    Sanchez MIP Can J Gastroenterol 25 (B) : 11B ~ 15B [2011]
  • Effect of prucalopride, a new enterokinetic agent, on gastrointestinal transit and anorectal function in healthy volunteers
    Poen AC Aliment Pharmacol Ther 13 : 1493 ~ 1497 - [1999]
  • Diagnosis and treatment of chronic constation--a European perspective
    Tack J Neurogastroenterol Motil 23 : 697 ~ 710 - [2011]
  • Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire
    Marquis P Scand J Gastroenterol 40 : 540 ~ 551 - [2005]
  • Clinical trial:the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study
    Quigley EM Aliment Pharmacol Ther 29 : 315 ~ 328 - [2009]
  • Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies
    Camilleri M Aliment Pharmacol Ther 32 : 1113 ~ 1123 - [2010]
  • Chronic constipation: new diagnostic and treatment approaches
    Lacy BE Therap Adv Gastroenterol 5 : 233 ~ 247 - [2012]
  • Chronic constipation: an evidence-based review
    Leung L J Am Board Fam Med 24 : 436 ~ 451 [2011]
  • Chronic constipation: a survey of the patient perspective
    Johanson JF Aliment Pharmacol Ther 25 : 599 ~ 608 - [2007]
  • Annex 1: Summary of product characteristics
  • An epidemiological survey of constipation in canada: definitions, rates, demographics, and predictors of health care seeking
    Pare P Am J Gastroenterol 96 : 3130 ~ 3137 [2001]
  • A placebo-controlled trial of prucalopride for severe chronic constipation
    Camilleri M N Engl J Med 358 : 2344 ~ 2354 - [2008]
  • A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation
    Wald A Aliment Pharmacol Ther 28 : 917 ~ 930 - [2008]
  • A longitudinal survey of self-reported bowel habits in the United States
    Everhart JE Dig Dis Sci 34 : 1153 ~ 1162 - [1989]